RLAY
Relay Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$19.39-2.64%
Price as of Jul 20, 2026
RLAY earnings
Relay Therapeutics, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 6, 2026in NaN days
EPS est $-0.41 · Revenue est $960000
Track record
Beat EPS in 7 of 12 quarters
Avg surprise +2.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 19, 2026 | $-0.35 | $-0.41 | -17.1% | $3M | -46.2% |
| Nov 6, 2025 | $-0.39 | $-0.43 | -10.3% | — | — |
| Aug 7, 2025 | $-0.49 | $-0.41 | +16.3% | $677000 | +4637.6% |
| Feb 26, 2025 | $-0.57 | $-0.45 | +21.1% | — | — |
| May 2, 2024 | $-0.70 | $-0.62 | +11.4% | $10M | +33256.7% |
| Feb 22, 2024 | $-0.76 | $-0.67 | +11.8% | $1000 | -99.2% |
| Nov 2, 2023 | $-0.83 | $-0.54 | +34.9% | $25M | +6711.4% |
| May 4, 2023 | $-0.70 | $-0.78 | -11.4% | $226000 | +18.9% |
| Feb 23, 2023 | $-0.71 | $-0.56 | +21.1% | $253000 | -6.8% |
| Nov 3, 2022 | $-0.71 | $-0.76 | -7.0% | $344000 | -80.9% |
| Aug 4, 2022 | $-0.62 | $-0.71 | -14.5% | $365000 | -82.5% |
| May 5, 2022 | $-0.63 | $-0.61 | +3.2% | $419000 | +151.4% |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-06.